Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • K Offline
    K Offline
    Klarussen
    wrote on sidst redigeret af
    #1211

    Så er jeg med på holdet igen, tankede godt op i 2185 i går og solgte lidt i dag (for tidligt) i 2210. Kunne ikke blive ved med at vente på 2150 😉 Fantastisk firma, fantastisk fremtid, fantastisk chef og fantastisk forum 🙂 Skulle den ramme 2150 tanker jeg videre op der.

    1 Reply Last reply
    0
    • L Offline
      L Offline
      lahn1
      wrote on sidst redigeret af
      #1212

      Blev CD47 CPI TTI-622 afskrevet som mulig combi med DAR ?

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #1213

        H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Genmab (NASDAQ:GMAB) A/S on Wednesday, setting a price target of $44

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #1214

          Upcoming Events : https://ir.genmab.com/events-and-presentations#content

          1 Reply Last reply
          0
          • K Offline
            K Offline
            kkjoel
            wrote on sidst redigeret af
            #1215

            @pens - jeg citerede blot Macabo. Du kunne jo starte med at læse det indlæg, der er henvist til!

            1 Reply Last reply
            0
            • K Offline
              K Offline
              kkjoel
              wrote on sidst redigeret af
              #1216

              Men Macabo tror jeg ikke kommer til at svare.. så fred med det
              🙂

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #1217

                Janssen's Teclistamab Received FDA Orphan Drug Designation for Treatment of Multiple Myeloma on November 24

                1 Reply Last reply
                0
                • DarvinD Offline
                  DarvinD Offline
                  Darvin
                  wrote on sidst redigeret af
                  #1218

                  Måske nævnt - men nyt kursmål i US: Truist Securities raises target price to $42 from $41

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #1219

                    @peter12 did you listen to the whole Novartis call or only the CEO intro?

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #1220

                      NICE : new option in cancerdrugs. https://www.nice.org.uk/news/article/new-option-for-people-with-difficult-to-treat-multiple-myeloma-is-recommended-for-use-in-cancer-drugs-fund-by-nice

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        peter12
                        wrote on sidst redigeret af
                        #1221

                        @EL_ I think its still online ? But that was what he said

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #1222

                          It also provided its own 2025 sales estimates for a number of key brands, including established growth drivers – Cosentyx ($5.6 billion), Entresto ($4.9 billion) and Kisqali ($1.6 billion), recent launches – Zolgensma ($2 billion), Kesimpta ($1.8 billion) and Piqray ($1.3 billion) - and the approval pending inclisiran ($1.4 billion).

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #1223

                            Just a moment...

                            favicon

                            (www.firstwordpharma.com)

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #1224

                              yes, i heard that , but i stopped after 1/2 hour, because they did not follow the presentation anymore, too long to sit through everything, i was wondering if they said more later on, on the number of subscriptions

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #1225

                                in the presentation it reads : 95%+ (~6000) of MS prescribing targets reached

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1226

                                  Solsen thought that means 6,000 prescriptions, I am not so sure, so hoping for clarification

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GeorgeBest
                                    wrote on sidst redigeret af
                                    #1227

                                    E L - why not post a question for Fridays q/a

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #1228

                                      yes, i can try, if nobody here knows. Doubt he'll answer that though

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #1229

                                        Well I dont know. More likely its the number of physicians Novartis salesforce are targeting.

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #1230

                                          Wonder what 5,2% NBRx is in numbers - New of brand presciptions ?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger